Get the Stockscreener App
1.32
3.13%
0.04
Werewolf Therapeutics Inc stock is traded at $1.32, with a volume of 114.68K.
It is up +3.13% in the last 24 hours and down -5.71% over the past month.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
See More
Previous Close:
$1.28
Open:
$1.28
24h Volume:
114.68K
Relative Volume:
0.25
Market Cap:
$60.36M
Revenue:
$19.94M
Net Income/Loss:
$-37.37M
P/E Ratio:
-1.2692
EPS:
-1.04
Net Cash Flow:
$-33.38M
1W Performance:
-0.75%
1M Performance:
-5.71%
6M Performance:
-4.35%
1Y Performance:
-40.00%
1-Day Range:
$1.28
$1.37
1-Week Range:
$1.20
$1.37
52-Week Range:
$0.595
$4.18
Werewolf Therapeutics Inc Stock (HOWL) Company Profile
Name
Werewolf Therapeutics Inc
Sector
Industry
Phone
617-952-0555
Address
200 TALCOTT AVENUE, WATERTOWN
Compare HOWL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HOWL
Werewolf Therapeutics Inc
|
1.32 | 59.68M | 19.94M | -37.37M | -33.38M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-03-24 | Initiated | JMP Securities | Mkt Outperform |
| Aug-24-23 | Initiated | Wedbush | Outperform |
| Jun-06-23 | Resumed | Jefferies | Buy |
| Sep-10-21 | Initiated | BofA Securities | Buy |
| May-25-21 | Initiated | Evercore ISI | Outperform |
| May-25-21 | Initiated | H.C. Wainwright | Buy |
| May-25-21 | Initiated | Jefferies | Buy |
| May-25-21 | Initiated | SVB Leerink | Outperform |
View All
Werewolf Therapeutics Inc Stock (HOWL) Latest News
What momentum shifts mean for Werewolf Therapeutics Inc.2025 Earnings Impact & Free Technical Pattern Based Buy Signals - Newser
Will Werewolf Therapeutics Inc. stock benefit from AI tech trends2025 Key Highlights & Daily Profit Maximizing Trade Tips - Newser
Statistical indicators supporting Werewolf Therapeutics Inc.’s strengthMarket Growth Review & Capital Protection Trading Alerts - Newser
Is Werewolf Therapeutics Inc. stock poised for growthEarnings Beat & Technical Buy Zone Confirmation - Newser
Is Werewolf Therapeutics Inc. meeting your algorithmic filter criteriaTreasury Yields & Weekly Hot Stock Watchlists - Newser
What recovery options are there for Werewolf Therapeutics Inc.2025 Technical Overview & Low Drawdown Trading Strategies - Newser
Why Werewolf Therapeutics Inc. stock attracts strong analyst attentionJuly 2025 Volume & Daily Chart Pattern Signal Reports - beatles.ru
Smart tools for monitoring Werewolf Therapeutics Inc.’s price actionJuly 2025 Market Mood & AI Forecasted Stock Moves - Newser
How to monitor Werewolf Therapeutics Inc. with trend dashboards2025 Trade Ideas & Weekly Hot Stock Watchlists - Newser
Custom watchlist performance reports with Werewolf Therapeutics Inc.GDP Growth & Verified High Yield Trade Plans - Newser
Strategies to average down on Werewolf Therapeutics Inc.2025 Bull vs Bear & Daily Oversold Bounce Ideas - Newser
Werewolf Therapeutics Inc. stock momentum explained2025 Market Outlook & Daily Volume Surge Trade Alerts - Newser
Using Bollinger Bands to evaluate Werewolf Therapeutics Inc.2025 Retail Activity & Low Drawdown Investment Strategies - Newser
Can momentum traders help lift Werewolf Therapeutics Inc.2025 Volatility Report & Low Drawdown Trading Techniques - Newser
What is HC Wainwright’s Estimate for HOWL Q3 Earnings? - Defense World
When is the best time to exit Werewolf Therapeutics Inc.Earnings Miss & Short-Term High Return Strategies - Newser
How institutional ownership impacts Werewolf Therapeutics Inc. stockEntry Point & Free Verified High Yield Trade Plans - Newser
Werewolf Therapeutics Faces Regulatory and Financial Challenges Amid FDA Disruptions - MSN
Real time alert setup for Werewolf Therapeutics Inc. performanceJuly 2025 Market Mood & Daily Oversold Stock Bounce Ideas - Newser
Why Werewolf Therapeutics Inc. is moving todayEarnings Recap Summary & Weekly Top Gainers Trade List - Newser
AI Tools Suggest Werewolf Therapeutics Inc. May Outperform This Week - sundaytimes.kr
Relative strength of Werewolf Therapeutics Inc. in sector analysisJuly 2025 Levels & Community Trade Idea Sharing Platform - Newser
Werewolf Reports No Revenue in Fiscal Q2 - AOL.com
Analyzing Werewolf Therapeutics Inc. with multi timeframe chartsDollar Strength & Fast Entry High Yield Stock Tips - Newser
Using Python tools to backtest Werewolf Therapeutics Inc. strategies2025 Market Sentiment & Short-Term High Return Ideas - Newser
Is Werewolf Therapeutics Inc. Stock a Good Fit for Conservative InvestorsJuly 2025 Price Swings & High Conviction Trade Alerts - Newser
Using data filters to optimize entry into Werewolf Therapeutics Inc.Market Trend Review & Community Verified Watchlist Alerts - Newser
Full technical analysis of Werewolf Therapeutics Inc. stockEarnings Overview Summary & AI Forecast Swing Trade Picks - Newser
Short interest data insights for Werewolf Therapeutics Inc.2025 Geopolitical Influence & Capital Protection Trading Alerts - Newser
Using economic indicators to assess Werewolf Therapeutics Inc. potentialPortfolio Profit Report & Smart Allocation Stock Tips - Newser
Is Werewolf Therapeutics Inc. backed by strong institutional buyingWeekly Earnings Recap & Smart Investment Allocation Insights - sundaytimes.kr
Using data models to predict Werewolf Therapeutics Inc. stock movementJobs Report & Technical Pattern Based Buy Signals - Newser
Werewolf Therapeutics reports Q2 EPS (40c), consensus (37c) - MSN
Werewolf Therapeutics Reports Q2 2025 Financial Results - MSN
Werewolf Therapeutics Inc Stock (HOWL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Werewolf Therapeutics Inc Stock (HOWL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Director |
May 14 '25 |
Buy |
0.98 |
162,539 |
159,288 |
6,237,482 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
May 13 '25 |
Buy |
0.98 |
52,974 |
51,915 |
6,074,943 |
| MPM BioVentures 2014, L.P. | 10% Owner |
Mar 27 '25 |
Sale |
1.05 |
1,963 |
2,061 |
3,208,793 |
| EVNIN LUKE | Director |
Mar 27 '25 |
Sale |
1.05 |
2,425 |
2,546 |
4,309,860 |
| GADICKE ANSBERT | 10% Owner |
Mar 27 '25 |
Sale |
1.05 |
4,386 |
4,605 |
6,718,670 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):